Clinical

Dataset Information

0

SMARTERscreen: A randomised controlled trial of the effect of patient SMS with health promotion messaging in general practice on participation in the National Bowel Cancer Screening Program.


ABSTRACT: Interventions: There are two intervention arms: Intervention arm 1 is an ‘SMS-only’ sent from general practice to patients, Intervention arm 2 is an ‘SMS-bundle’ - an SMS with additional video material sent from general practice to patients. The study is a cluster randomised controlled trial with the cluster unit being individual general practices. The intervention will be sent from general practices using an SMS service ‘GoShare’ depending on the cluster that the general practice has been randomised into. The SMS-only/SMS-bundle will be sent to eligible patients two weeks prior to when their National Bowel Cancer Screening Program (NBCSP) kit is due to arrive. The participants will only be sent one SMS-only or SMS-bundle. 1. The SMS-only is sent from a patient s general practice is to prompt patients to do the NBCSP kit. The SMS contains a greeting and the patient s first name, general practice name and telephone number, a GP endorsement of the NBCSP and the option to ‘opt-out’ of receiving future SMS. The wording in the SMS is: ‘Hi [insert patient first name]. Your free bowel cancer screening kit will arrive in the post soon. [insert general practice name] strongly encourages you to do this test. Call us on [insert general practice telephone number] if you have any questions. Reply STOP to opt out’. 2. The SMS-bundle is the SMS as described above, but with an web link to a GP message with the general practice logo and endorsing the NBCSP, a video of relatable people talking about why it is important to do the kit (approx 30 seconds long), an instructional video on how to do the kit (approx 45 seconds long), and a link to more information about the NBCSP. The wording is: ‘Hi [insert patient first name]. Your free bowel cancer screening kit will arrive in the Primary outcome: The primary outcome will be the difference in the proportion of patients who have a faecal occult blood test (FOBT) result recorded by the National Cancer Screening Register between the control arms and both interventions. This will be analysed by sex, age and location.[ The time point will be 6 months after the intervention phase is completed (SMS has been sent to patients). ] Study Design: Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy

DISEASE(S): Bowel Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)

PROVIDER: 23128 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2471237 | ecrin-mdr-crc
| 2467212 | ecrin-mdr-crc
| PRJNA997789 | ENA
2021-11-18 | GSE140556 | GEO
| 2726190 | ecrin-mdr-crc
2010-03-08 | GSE16147 | GEO
2022-02-21 | MODEL2202170007 | BioModels
2019-12-26 | GSE126140 | GEO
| 2179622 | ecrin-mdr-crc
2010-03-08 | E-GEOD-16147 | biostudies-arrayexpress